Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#UrothelialCarcinoma

Home » #UrothelialCarcinoma
ESMO 2024 | Dr. Dingwei Ye Presents Promising Data on BL-B01D1 for Advanced Urothelial Carcinoma

ESMO 2024 | Dr. Dingwei Ye Presents Promising Data on BL-B01D1 for Advanced Urothelial Carcinoma

Posted by By Mourabit Halima 2024.11.15
At the ESMO 2024 Congress in Barcelona, Dr. Dingwei Ye from Fudan University Shanghai Cancer Center presented findings from a phase 2 study on BL-B01D1, a novel EGFR and HER3…
Read More
Recent Posts
  • Published in JCO! Professor Lin Shen’s Team Reports the World’s First Published Positive Phase III Data for a Dual PD-L1/TGF-β-Targeting Agent, Reshaping First-Line Treatment for HER2-Negative Advanced Gastric Cancer
  • “Zhong” Voice, “Hui” Insights Series, Episode 33: Exploring IL-1β Blockade Combined with Concurrent Chemoradiotherapy and Maintenance Immunotherapy in Unresectable Stage III NSCLC — An Interpretation of the CHORUS Study
  • Professor Hua Huang on Selecting Beneficiaries of Perioperative Gastric Cancer Therapy, Reassessing the Value of Conversion Surgery for Peritoneal Metastases, and the Path from Surgeon to “Clinical Scientist” for Young Surgeons | CGCC 2026
  • New Evidence, New Possibilities | Professor Lijun Tian: First Real-World Case of Andaritini Demonstrates Simultaneous Intracranial and Extracranial Responses Within Just Three Months in EGFR-Mutant Advanced NSCLC with Acquired Resistance
  • SIBCS 2026 | Professors Lu Gan, Huihui Li, and Jian Huang: From Mechanisms to Clinical Practice—ADC Sequencing Strategies and the Distinctive Value of Bodutuzumab in HER2-Positive Advanced Breast
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top